Our study demonstrated that YTHDC1‐depended Titin splicing is crucial for the postnatal heart development and normal cardiac function, which probably provides a potential target for treating DCM through tuning m6A modification of Titin mRNA. The gene discussed is YTHDC1; the disease is familial dilated cardiomyopathy.